메뉴 건너뛰기




Volumn 124, Issue 6, 2009, Pages 667-671

Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY)

Author keywords

Bariatric surgery; Obesity; Parnaparin; Prophylaxis; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; CREATININE; PARNAPARIN;

EID: 70449527717     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.04.021     Document Type: Article
Times cited : (20)

References (32)
  • 1
    • 34249657825 scopus 로고    scopus 로고
    • Bariatric surgery for morbid obesity
    • DeMaria E.J. Bariatric surgery for morbid obesity. N Engl J Med 356 (2007) 2176-2183
    • (2007) N Engl J Med , vol.356 , pp. 2176-2183
    • DeMaria, E.J.1
  • 2
    • 34748845711 scopus 로고    scopus 로고
    • Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity
    • DeMaria E.J., Murr M., Byrne T.K., Blackstone R., Grant J.P., Budak A., et al. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity. Ann Surg 246 (2007) 578-582
    • (2007) Ann Surg , vol.246 , pp. 578-582
    • DeMaria, E.J.1    Murr, M.2    Byrne, T.K.3    Blackstone, R.4    Grant, J.P.5    Budak, A.6
  • 4
    • 27544516002 scopus 로고    scopus 로고
    • Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients
    • Prystowsky J.B., Morasch M.D., Eskandari M.K., Hungness E.S., and Nagle A.P. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery 138 (2005) 759-763
    • (2005) Surgery , vol.138 , pp. 759-763
    • Prystowsky, J.B.1    Morasch, M.D.2    Eskandari, M.K.3    Hungness, E.S.4    Nagle, A.P.5
  • 5
    • 0041917329 scopus 로고    scopus 로고
    • Complications after laparoscopic gastric bypass: a review of 3464 cases
    • Podnos Y.D., Jimenez J.C., Wilson S.E., Stevens C.M., and Nguyen N.T. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 138 (2003) 957-961
    • (2003) Arch Surg , vol.138 , pp. 957-961
    • Podnos, Y.D.1    Jimenez, J.C.2    Wilson, S.E.3    Stevens, C.M.4    Nguyen, N.T.5
  • 6
    • 33845924755 scopus 로고    scopus 로고
    • Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery
    • Rocha A.T., de Vasconcellos A.G., da Luz Neto E.R., Araújo D.M., Alves E.S., and Lopes A.A. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg 16 (2006) 1645-1655
    • (2006) Obes Surg , vol.16 , pp. 1645-1655
    • Rocha, A.T.1    de Vasconcellos, A.G.2    da Luz Neto, E.R.3    Araújo, D.M.4    Alves, E.S.5    Lopes, A.A.6
  • 8
    • 3142670628 scopus 로고    scopus 로고
    • Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass
    • Gonzalez Q.H., Tishler D.S., Plata-Munoz J.J., Bondora A., Vickers S.M., Leath T., et al. Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 18 (2004) 1082-1084
    • (2004) Surg Endosc , vol.18 , pp. 1082-1084
    • Gonzalez, Q.H.1    Tishler, D.S.2    Plata-Munoz, J.J.3    Bondora, A.4    Vickers, S.M.5    Leath, T.6
  • 9
    • 0036174636 scopus 로고    scopus 로고
    • A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery
    • Scholten D.J., Hoedema R.M., and Scholten S.E. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12 (2002) 19-24
    • (2002) Obes Surg , vol.12 , pp. 19-24
    • Scholten, D.J.1    Hoedema, R.M.2    Scholten, S.E.3
  • 10
    • 0035659688 scopus 로고    scopus 로고
    • Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial
    • Kalfarentzos F., Stavropoulou F., Yarmenitis S., Kehagias I., Karamesini M., Dimitrakopoulos A., et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 11 (2001) 670-676
    • (2001) Obes Surg , vol.11 , pp. 670-676
    • Kalfarentzos, F.1    Stavropoulou, F.2    Yarmenitis, S.3    Kehagias, I.4    Karamesini, M.5    Dimitrakopoulos, A.6
  • 11
    • 28544453559 scopus 로고    scopus 로고
    • Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: Findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE study)
    • Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE study). Obes Surg 2005;15:1368-7.
    • (2005) Obes Surg , vol.15 , pp. 1368-1377
    • Hamad, G.G.1    Choban, P.S.2
  • 12
    • 36048961419 scopus 로고    scopus 로고
    • A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin
    • Kothari S.N., Lambert P.J., and Mathiason M.A. A comparison of thromboembolic and bleeding events following laparoscopic gastric bypass in patients treated with prophylactic regimens of unfractionated heparin or enoxaparin. Am J Surg 194 (2007) 709-711
    • (2007) Am J Surg , vol.194 , pp. 709-711
    • Kothari, S.N.1    Lambert, P.J.2    Mathiason, M.A.3
  • 13
    • 0034110220 scopus 로고    scopus 로고
    • Current practices in the prophylaxis of venous thromboembolism in bariatric surgery
    • Wu E.C., and Barba C.A. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 10 (2000) 7-13
    • (2000) Obes Surg , vol.10 , pp. 7-13
    • Wu, E.C.1    Barba, C.A.2
  • 14
    • 36949037548 scopus 로고    scopus 로고
    • Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion
    • Seddighzadeh A., Zurawska U., Shetty R., and Goldhaber S.Z. Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion. Thromb Haemost 98 (2007) 1220-1225
    • (2007) Thromb Haemost , vol.98 , pp. 1220-1225
    • Seddighzadeh, A.1    Zurawska, U.2    Shetty, R.3    Goldhaber, S.Z.4
  • 15
    • 0033926129 scopus 로고    scopus 로고
    • The effect of body weight on dalteparin pharmacokinetics. A preliminary study
    • Yee J.Y., and Duffull S.B. The effect of body weight on dalteparin pharmacokinetics. A preliminary study. Eur J Clin Pharmacol 56 (2000) 293-297
    • (2000) Eur J Clin Pharmacol , vol.56 , pp. 293-297
    • Yee, J.Y.1    Duffull, S.B.2
  • 16
    • 0029921343 scopus 로고    scopus 로고
    • Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans
    • Frydman A. Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis 26 (1996) 24-38
    • (1996) Haemostasis , vol.26 , pp. 24-38
    • Frydman, A.1
  • 18
    • 0036257203 scopus 로고    scopus 로고
    • Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study
    • Hainer J.W., Barrett J.S., Assaid C.A., Fossler M.J., Cox D.S., Leathers T., et al. Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study. Thromb Haemost 87 (2002) 817-823
    • (2002) Thromb Haemost , vol.87 , pp. 817-823
    • Hainer, J.W.1    Barrett, J.S.2    Assaid, C.A.3    Fossler, M.J.4    Cox, D.S.5    Leathers, T.6
  • 19
    • 4644308426 scopus 로고    scopus 로고
    • Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
    • Hirsh J., and Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 188 S-203S
    • (2004) Chest , vol.126
    • Hirsh, J.1    Raschke, R.2
  • 21
    • 2342591427 scopus 로고    scopus 로고
    • Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study
    • Desjardins L., Bara L., Boutitie F., Samama M.M., Cohen A.T., Combe S., et al. Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study. Arch Pathol Lab Med 128 (2004) 519-526
    • (2004) Arch Pathol Lab Med , vol.128 , pp. 519-526
    • Desjardins, L.1    Bara, L.2    Boutitie, F.3    Samama, M.M.4    Cohen, A.T.5    Combe, S.6
  • 24
    • 0024398566 scopus 로고
    • The relationship between anti-factor Xa level and clinical outcome in patients receiving low molecular weight heparin enoxaparin to prevent deep vein thrombosis after hip replacement
    • Levine M.N., Planes A., Hirsh J., Goodyear M., Vochelle N., and Gent M. The relationship between anti-factor Xa level and clinical outcome in patients receiving low molecular weight heparin enoxaparin to prevent deep vein thrombosis after hip replacement. Thromb Haemost 62 (1989) 940-944
    • (1989) Thromb Haemost , vol.62 , pp. 940-944
    • Levine, M.N.1    Planes, A.2    Hirsh, J.3    Goodyear, M.4    Vochelle, N.5    Gent, M.6
  • 25
    • 37249092150 scopus 로고    scopus 로고
    • Parnaparin: a review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disorders
    • McKeage K., and Keating G.M. Parnaparin: a review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disorders. Drugs 68 (2008) 105-122
    • (2008) Drugs , vol.68 , pp. 105-122
    • McKeage, K.1    Keating, G.M.2
  • 26
    • 33947628076 scopus 로고    scopus 로고
    • International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors
    • De Angelis C., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., et al. International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 364 (2004) 911-912
    • (2004) Lancet , vol.364 , pp. 911-912
    • De Angelis, C.1    Drazen, J.M.2    Frizelle, F.A.3    Haug, C.4    Hoey, J.5    Horton, R.6
  • 27
    • 70449536442 scopus 로고    scopus 로고
    • Pharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: a prospective randomised study comparing two different doses of parnaparin
    • [abs]
    • Legnani C., Imberti D., Cini M., Dedola D., Baldini E., Della Valle E., et al. Pharmacodynamic of low molecular weight heparin (LMWH) in obese subjects undergoing bariatric surgery: a prospective randomised study comparing two different doses of parnaparin. Haematologica 91 (2006) 89 [abs]
    • (2006) Haematologica , vol.91 , pp. 89
    • Legnani, C.1    Imberti, D.2    Cini, M.3    Dedola, D.4    Baldini, E.5    Della Valle, E.6
  • 29
    • 0034945986 scopus 로고    scopus 로고
    • Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism
    • Wilson S.J., Wilbur K., Burton E., and Anderson D.R. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism. Haemostasis 31 (2001) 42-48
    • (2001) Haemostasis , vol.31 , pp. 42-48
    • Wilson, S.J.1    Wilbur, K.2    Burton, E.3    Anderson, D.R.4
  • 30
    • 0037092628 scopus 로고    scopus 로고
    • Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis
    • Heinzmann M., Baerlocher G.M., Steinmann F., Horber F.F., and Wuillemin W. Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis. Thromb Res 106 (2002) 179-181
    • (2002) Thromb Res , vol.106 , pp. 179-181
    • Heinzmann, M.1    Baerlocher, G.M.2    Steinmann, F.3    Horber, F.F.4    Wuillemin, W.5
  • 31
    • 0025160385 scopus 로고
    • Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
    • Handeland G.F., Abildgaard U., Holm H.A., and Arnesen K.E. Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 39 (1990) 107-112
    • (1990) Eur J Clin Pharmacol , vol.39 , pp. 107-112
    • Handeland, G.F.1    Abildgaard, U.2    Holm, H.A.3    Arnesen, K.E.4
  • 32
    • 33747120659 scopus 로고    scopus 로고
    • Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
    • Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
    • (2006) Ann Intern Med , vol.145 , pp. 247-254
    • Levey, A.S.1    Coresh, J.2    Greene, T.3    Stevens, L.A.4    Zhang, Y.L.5    Hendriksen, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.